![Timothy Corn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Timothy H.
Corn, MD, is an Executive Director & Chief Medical Officer at Oxford Cannabinoid Technologies Holdings Plc, a Chairman at Neuro Foundation and a Chief Medical Officer at Nodenza, Inc. He is on the Board of Directors at Oxford Cannabinoid Technologies Holdings Plc and Nerve Tumours Uk.
Dr. Corn was previously employed as an Independent Non-Executive Director by Physiomics Plc, a Chief Medical Officer by Izana Bioscience Ltd., an Independent Non-Executive Director by HRA Pharma Development SARL, an Independent Non-Executive Director by ReNeuron Group Plc, an Independent Non-Executive Director by Circassia Group Plc, a Non-Executive Director by NIOX Healthcare Ltd., a Chief Medical Officer by Zeneus Pharma Ltd., a Principal by Athena Neurosciences LLC, a Principal by Elan Corp.
Plc, a Chief Medical Officer by Eusa Pharma International Ltd., a Chief Medical Officer by EUSA Pharma, Inc., a Chief Medical Officer by Jazz Pharmaceuticals UK Ltd., a Non-Executive Director by Neurocentrx Pharma Ltd., and a Principal by Organon Pharma (UK) Ltd. He received his graduate degree from Imperial College London and a doctorate degree from King's College London.
| Empresas | Cargo | Inicio |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Director Técnico/Científico/I+D | 08/06/2023 |
Neuro Foundation
 Neuro Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Presidente | 01/07/2013 |
Nodenza, Inc.
 Nodenza, Inc. Investment ManagersFinance Nodenza, Inc. is an active manager. | Director Técnico/Científico/I+D | - |
Nerve Tumours Uk | Director/Miembro de la Junta | 01/07/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| PHYSIOMICS PLC | Director/Miembro de la Junta | 29/04/2026 |
| RENEURON GROUP PLC | Presidente | 30/06/2021 |
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Director Técnico/Científico/I+D | 01/04/2021 |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Director/Miembro de la Junta | 01/07/2019 |
| NIOX GROUP PLC | Director/Miembro de la Junta | 26/05/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 20 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Provides pharmaceutical products | Distribution Services |
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
NIOX Healthcare Ltd.
 NIOX Healthcare Ltd. Pharmaceuticals: OtherHealth Technology Develops medicines for allergic and auto-immune diseases | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physiomics Plc
 Physiomics Plc Miscellaneous Commercial ServicesCommercial Services Provides computational systems biology services and develops cutting-edge mathematical models | Commercial Services |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Health Technology |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets late-stage oncology, oncology supportive care and critical care products | Health Technology |
Neurocentrx Pharma Ltd.
 Neurocentrx Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Eusa Pharma International Ltd.
 Eusa Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products | Health Technology |
Neuro Foundation
Neuro Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Niox Group Plc
 Niox Group Plc Medical/Nursing ServicesHealth Services Develops immuno therapies to control immune system responses | Health Services |
Izana Bioscience Ltd.
Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Health Technology |
Nerve Tumours Uk | |
Oxford Cannabinoid Technologies Holdings Plc
 Oxford Cannabinoid Technologies Holdings Plc Pharmaceuticals: MajorHealth Technology Provides cannabinoid drug development services | Health Technology |
Nodenza, Inc.
Nodenza, Inc. Investment ManagersFinance Nodenza, Inc. is an active manager. | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
